A drug identified by the U.S. Food and Drug Administration as being developed for a disease that affects fewer than 200,000 people in the U.S. Orphan drug status helps encourage research and development of these drugs for less common diseases.
An educational product of HOPES, not to be used in place of medical care. For more information about HOPES, click here. To contact HOPES with comments or questions, click here. Designed by Stephanie Liou. Based on Provision.